Business Segments West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.95 USD | +7.48% |
|
+7.71% | -9.52% |
| 05/02 | West Pharmaceutical Services, Inc. - Special Call | |
| 03/02 | Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390 | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Instruments | ||||||||||
Proprietary Products | 164.86Cr | 231.73Cr | 240.68Cr | 239.73Cr | 233.45Cr | |||||
Total Assets | 179.83Cr | 215.26Cr | 257.83Cr | 262.91Cr | 262.11Cr | |||||
CAPEX | -14Cr | -22Cr | -24Cr | -26Cr | -25Cr | |||||
Gross Profit | 68Cr | 109.39Cr | 105.33Cr | 103.4Cr | 90Cr | |||||
D&A | 8.46Cr | 9.38Cr | 9.69Cr | 11Cr | 13Cr | |||||
Operating Income | 43Cr | 80Cr | 78Cr | 71Cr | 58Cr | |||||
Contract-Manufactured Products | 50Cr | 51Cr | 48Cr | 55Cr | 56Cr | |||||
Total Assets | 41Cr | 44Cr | 48Cr | 53Cr | 61Cr | |||||
CAPEX | -2.5Cr | -2.66Cr | -3.4Cr | -9.02Cr | -12Cr | |||||
Gross Profit | 8.56Cr | 8.38Cr | 8.29Cr | 9.6Cr | 9.8Cr | |||||
D&A | 2.04Cr | 2.11Cr | 1.9Cr | 2.04Cr | 2.13Cr | |||||
Operating Income | 6.86Cr | 6.72Cr | 6.04Cr | 7.21Cr | 7.23Cr | |||||
Pharmaceutical Packaging Systems | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Consumables | ||||||||||
Pharmaceutical Delivery Systems | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Corporate and Unallocated | -3L | -4L | -3L | - | - | |||||
Total Assets | 58Cr | 72Cr | 56Cr | 67Cr | 41Cr | |||||
CAPEX | -99L | -88L | -1.33Cr | -1.27Cr | -95L | |||||
D&A | 41L | 74L | 47L | 40L | 38L | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -3.4Cr | -3.75Cr | -2.37Cr | -2.33Cr | -1.87Cr | |||||
Operating Income | -5.21Cr | -6.34Cr | -5.91Cr | -6.83Cr | -5.86Cr | |||||
Gross Profit | - | -19L | - | -8L | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 98Cr | 119.8Cr | 128.65Cr | 123.85Cr | 123.08Cr | |||||
Total Assets | 41Cr | 50Cr | 61Cr | 76Cr | 83Cr | |||||
Other European Countries | 24Cr | 34Cr | 36Cr | 39Cr | 39Cr | |||||
Total Assets | 6.68Cr | 6.51Cr | 8.18Cr | 9.92Cr | 9.81Cr | |||||
Germany | 28Cr | 47Cr | 40Cr | 41Cr | 37Cr | |||||
Total Assets | 11Cr | 12Cr | 14Cr | 18Cr | 19Cr | |||||
Other | 25Cr | 36Cr | 36Cr | 35Cr | 34Cr | |||||
Total Assets | 15Cr | 16Cr | 18Cr | 19Cr | 21Cr | |||||
Ireland | 23Cr | 25Cr | 24Cr | 29Cr | 32Cr | |||||
Total Assets | 20Cr | 19Cr | 18Cr | 21Cr | 30Cr | |||||
France | 17Cr | 21Cr | 24Cr | 28Cr | 24Cr | |||||
Total Assets | 7.6Cr | 8.61Cr | 6.88Cr | 7.85Cr | 8.47Cr |
- Stock Market
- Equities
- WST Stock
- Financials West Pharmaceutical Services, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition